. The transcriptional repressor Bcl6 promotes GC-Tfh cell formation by repressing the expression of transcription factors, such as T-bet, GATA3, and RORgt, which are required for the differentiation of other effector cell lineages (2, 3) . Repression by Bcl6 depends on two domains: a middle repression domain 2 (RD2) domain and an N-terminal BTB domain (4, 5) that interact with corepressors. The RD2 domain can recruit the metastasisassociated 3 corepressor (6), whereas the BTB domain can bind Bcl6-interacting corepressor (BCOR), nuclear receptor corepressor, or nuclear receptor corepressor 2 (7). BCOR potentiates transcriptional repression by Bcl6 as part of a variant Polycomb complex, which may make epigenetic modifications that silence target genes (8) .
The role that these corepressors play in transcriptional repression by Bcl6 in T cells is unclear. Mutation of the Bcl6 RD2 domain leads to partial reduction in GC-Tfh cell differentiation (9) . In contrast, it was reported that GC-Tfh cell formation following SRBC immunization is normal in mice with a mutated Bcl6 BTB domain (10) , suggesting that none of the BTB-interacting corepressors are involved in GC-Tfh cell differentiation. However, it remained possible that a defect was not detected in this experiment because relevant peptide:MHC class II (p:MHCII)-specific T cells were not monitored. Indeed, in the accompanying study, Crotty and colleagues found that the Bcl6 BTB domain contributes to GC-Tfh cell formation by viral p:MHCII-specific CD4 + T cells during acute infection (11) . In this study, we evaluated the role of BCOR in GC-Tfh cell formation. We found that BCOR deficiency in T cells led to a defect in p:MHCII-specific GC-Tfh cell formation that correlated with reduced formation of plasma cells and GC B cells. Therefore, BCOR was required for optimal GC-Tfh cell formation by p:MHCII-specific CD4 + T cells, perhaps through its capacity to interact with the Bcl6 BTB domain.
Materials and Methods

Mice
The conditional Bcor allele (Bcor f l ), which contains LoxP sites flanking Bcor exons 9 and 10, was generated by homologous recombination (J.A. Wamstad, C.M. Corcoran, M.Y. Hamline, M.D. Gearhart, M. Hemberger, and V.J. Bardwell, manuscript in preparation). Cre-mediated deletion results in a premature stop codon and a null allele. Bcor fl/+ mice were backcrossed with C57BL/6NCr mice (National Cancer Institute-Frederick) for .6 (Fig. 1) or .10 generations (Figs. 3, 4 Fig. 2 were housed in specific pathogen-free conditions, whereas other mice were housed in a conventional facility at the University of Minnesota. All experimental protocols were performed in accordance with guidelines of the University of Minnesota Institutional Animal Care and Use Committee and National Institutes of Health.
Infections and immunizations
Mice were infected i.v. with 10 7 actA-deficient Listeria monocytogenes bacteria expressing FliC peptide RFNSAITNLGN (12) or 2W peptide EAWGA-LANWAVDSA fused to chicken OVA (13), or they were immunized by i.p. injection of 200 ml of 0.6 mg 2W peptide conjugated to, or mixed with, 25 mg PE (2W-PE) emulsified in CFA (Sigma-Aldrich). The conjugate was formed by mixing biotinylated 2W peptide (GenScript) with streptavidin-PE (ProZyme) at a 4:1 ratio.
Cell enrichment and flow cytometry
Spleen and lymph node (LN) cells were divided for separate enrichments of CD4 + T cells and B cells. For p:MHCII-specific CD4 + T cell enrichment, cells were stained with CXCR5 (2G8; BD) and I-A b tetramers containing listeriolysin O peptide NEKYAQAYPNVS (LLOp) or 2W peptide (14) . Before PE-specific B cell enrichment, suspensions were incubated with Dispase (Invitrogen), collagenase P (Roche), and DNase I (Roche) to release all B cell subsets. Enrichment was performed as previously described by mixing cell suspensions with 1 mg PE (ProZyme) (15) . PE-or p:MHCII-bound cells were enriched using magnetic beads (Miltenyi Biotec), as previously described (15 
Statistical analysis
Statistical tests were performed using Prism (GraphPad) software, and p values were obtained using two-tailed unpaired t tests with a 95% confidence interval.
Results and Discussion
BCOR deficiency in T cells causes a defect in GC-Tfh cell differentiation
Given that BCOR, nuclear receptor corepressor, and nuclear receptor corepressor 2 potentiate Bcl6 repression (16) (17) (18) , it was possible that one or more of these corepressors promotes Tfh cell formation. We assessed the role of BCOR using (Fig. 1A, 1B) . As shown in previous studies (13, (19) (20) (Fig. 1C-E) . BCOR-deficient LLOp:I-A b -specific CD4 + T cells produced an even larger effector cell population than that generated by WT cells (Fig. 1B) . The BCOR-deficient population had a higher fraction of Th1 cells and a greater number of Th1 and Tfh cells (Fig. 1D, 1E ) but a much lower fraction and number of GC-Tfh cells than did the comparable WT population. Thus, BCOR expression in T cells is critical for GC-Tfh cell differentiation during L. monocytogenes infection. A caveat to these experiments is that BCOR deficiency in CD8 + T cells, which play an important role in the control of L. monocytogenes bacteria (22) , could have altered the infection in a way that indirectly affected GC-Tfh cell formation. Therefore, we examined the effects of BCOR deficiency on GC-Tfh cell differentiation during an immune response to a nonreplicating Ag. WT and Bcor f l/Y Lck-Cre + mice were immunized i.p. with a CFA emulsion containing 2W peptide mixed with PE (2W + PE) or a 2W-PE conjugate. In the latter situation, PE-specific B cells that internalize 2W-PE through the BCR produce PE peptide:I- effector cells generated by 2W-PE immunization on day 7 were similar in WT and Bcor fl/Y Lck-Cre + mice, indicating that BCOR is not a regulator of T cell clonal expansion driven by a nonreplicating Ag (Fig. 3A) . However, BCOR-deficient 2W: I-A b -specific effector cells exhibited increased differentiation of CXCR5 2 non-Tfh cells and decreased differentiation of GCTfh cells relative to WT cells (Fig. 3B, 3D ). Cells also were stained for intracellular T cell lineage-defining transcription factors to confirm a GC-Tfh cell defect. As shown in Fig. 3C , ∼1% of the 2W:I-A b -specific WT effector cells were T-bet + Bcl6
2 Th1 cells, whereas 30% were T-bet 2 Bcl6 + GC-Tfh cells, indicating that i.p. peptide priming in CFA is a poor Th1 cell stimulus and a good Tfh cell stimulus on day 7 (Fig. 3B-E) . The BCOR-deficient 2W:I-A b -specific effector cell population contained ∼3-fold more T-bet + Bcl6 2 Th1 cells and 2-fold less T-bet 2 Bcl6 + GC-Tfh cells than did the comparable population in WT mice. Therefore, BCOR was required for maximal GC-Tfh cell differentiation in response to a peptide Ag. The fact that BCOR was not essential indicates that some aspect of CFA priming, perhaps prolonged Ag presentation (23, 24) , promotes BCOR-independent GC-Tfh cell formation.
A reduction in GC-Tfh cells due to BCOR deficiency correlates with defects in B cell activation GC-Tfh cells help GC B cells become long-lived plasma cells and memory cells (1) . Therefore, we assessed B cell activation in Bcor f l/Y Lck-Cre + mice to determine whether the defect in GC-Tfh cell formation was associated with defects in B cell activation. As shown in Fig. 4 , PE-specific B cells in WT mice increased from ∼50,000 cells on the day of immunization to ∼400,000 cells on day 7 after injection of 2W-PE/CFA. The PE-specific B cell population consisted of plasma cells expressing large amounts of intracellular Ig H and L chains (IgG [H+L]) (Fig. 4A) , B220 high CD38 + GL7 2 naive or memory B cells, and CD38
2 GL7 + GC B cells (Fig. 4A) . PEspecific B cells in Bcor fl/Y Lck-Cre + mice increased much less than did WT cells after immunization and produced significantly fewer plasma cells and GC cells (Fig. 4B) .
Our data show that BCOR deficiency hinders the differentiation of p:MHCII-specific GC-Tfh cells, which, in turn, reduces the formation of plasma cells and GC B cells. The recent study by Nance et al. (11) showing that the Bcl6 BTB domain contributes to optimal GC-Tfh cell formation raises the likely possibility that the effects of BCOR on GC-Tfh cell differentiation depend on its interaction with the Bcl6 BTB domain. However, it should be noted that Huang et al. (10) found that GC-Tfh cell differentiation was induced normally by SRBCs in mice with a mutated Bcl6 BTB domain incapable of binding BCOR. Therefore, it is also possible that BCOR fosters GC-Tfh cell formation by a mechanism that depends on BCOR but not the Bcl6 BTB domain. Such a mechanism could involve BCOR interaction with other known (25) (26) (27) (28) (29) or yet-to-be-identified BCORbinding transcription factors. Additional studies are required to identify the molecular interactions that govern BCORdependent control of GC-Tfh cell formation during different immune responses.
